DNA Single Nucleotide Polymorphisms as Predictors of Toxicity

UnknownOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2017

Conditions
Ovarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms
Trial Locations (1)

32804

Florida Hospital Cancer Institute, Orlando

Sponsors
All Listed Sponsors
lead

OvaGene Oncology, Inc.

INDUSTRY